We wish to inform you that on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today i.e. on January 28, 2026 has, ....
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals Ltd has appointed Mr. Bhavesh Mahajan (DIN: 09614108) as an Additional Independent Director of the company for a period of five years, effective January 28, 2026 to January 27, 2031, subject to shareholder approval. The appointment was made on the recommendation of the Nomination and Remuneration Committee and approved by the Board at its meeting held on January 28, 2026. Mr. Bhavesh Mahajan is a Chartered Accountant with over 19 years of experience in audit, taxation, financial consultancy, and corporate advisory, and currently serves as Senior Partner of M/s Bhavesh Mahajan & Co., Chartered Accountants, Amritsar. He is not related to any existing Director and has confirmed he is not debarred from holding directorship by SEBI or any other authority.
This is a routine board strengthening move with the addition of an experienced finance professional as an independent director. It is unlikely to have a material impact on the stock price, though it adds financial expertise to the board.